FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver

Journal of Surgical Research

Volumn 60, Issue 1, 1996, Pages 142-146

  Dhar, Dipok Kumar ^a   Takemoto, Yoshinari ^a   Nagasue, Naofumi ^a   Uchida, Masaaki ^a   Ono, Takashi ^a   Nakamura, Teruhisa ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPASE A2; TACROLIMUS; XANTHINE DEHYDROGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DOG; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0030038818     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0023     Document Type: Article

References (31)

1. Starzel, T. E., Porter, K. A., Mazzaferro, V., et al. Hepatotrophic effect of FK506 in dogs. Transplantation 51: 67, 1991.
2. Dhar, D. K., Nagasue, N., Kimoto, T., et al. The salutary effect of FK 506 in ischemia-reperfusion injury of the canine liver. Transplantation 54: 583, 1992.
3. Dhar, D. K., Nagasue, N., Uchida, M., et al. Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. Transplantation 56: 1555, 1993.
4. Sakr, M. F., Hassanein, T. I., Zetti, G. M., et al. FK 506 ameliorates the hepatic injury associated with ischemia. Life Sci. 47: 687, 1990.
5. Francavilla, A., Starzel, T. E., Barone, M., et al. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology 14: 140, 1991.
6. Shen, A. C., and Jennings, R. B. Myocardial calcium and magnesium in acute ischemic injury. Am. J. Pathol. 67: 417, 1972.
7. Schanne, F. A. X., Kane, A. B., Young, E. E., et al. Calcium dependence of toxic cell death: A common final pathway. Science 206: 700, 1979.
8. Deakin, D. C., Fagan, E. A., and Williams, R. Cytoprotective effects of calcium channel blockers: Mechanisms of potential applications in hepatocellular injury. J. Hepatol. 12: 251, 1991.
9. Griffiths, E. J., and Halestrap, A. P. Further evidence that cyclosporine A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl Cis-trans isomerase. Biochem. J. 274: 611, 1991.
10. ++, inorganic phosphate and oxidative stress. Eur. J. Biochem. 178: 489, 1988.
11. ++ fluxes in isolated hepatocytes. J. Biol. Chem. 260: 13613, 1985.
12. ++ release to cyclosporine A and related compounds. Biochem. Pharmacol. 45: 641, 1993.
13. Synder, J. W., Pastorino, J. G., Attie, A. M., et al. Protection by cyclosporin A of cultured hepatocytes from the toxic consequences of the loss of mitochondrial energization produced by 1-methyl-4-phenylpyridinium. Biochem. Pharmacol. 44: 833, 1992.
14. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265, 1951.
15. McCord, J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312: 159, 1985.
16. Gores, G. J., Nieminen, A. L., Fleishman, K. E., et al. Intracellular pH during chemical hypoxia in cultured rat hepatocytes. J. Clin. Invest. 83: 386, 1989.
17. Braunwald, E., and Kloner, R. A. Myocardial reperfusion: A double-edged sword? J. Clin. Invest. 76: 1713, 1985.
18. Schreiber, S. L., Liu, J., Albers, M. W., et al. Immunophilinligand complexes as probe of Intracellular signaling pathways. Transplant Proc. 23: 2839, 1991.
19. Siekierka, J. J., Hung, S. H. Y., Poe, M., et al. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341: 755, 1989.
20. ++ -induced large-amplitude swelling of liver and heart mitochondria by cyclosporine is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerage and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 268: 153, 1990.
21. Kay, J. E., Moore, A. L., Doe, S. E. A., et al. The mechanism of action of FK 506. Transplant Proc. 22: 96, 1990.
22. Harding, M. W., Galat, A., Uehling, D. E., et al. A receptor for immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341: 758, 1989.
23. Harrison, R. K., and Stein, R. L. Substrate specificity of the peptidyl-prolyl cis-trans isomerase activity of cyclophilin and FK-506 binding protein: Evidence for the existance of a family of distinct enzymes. Biochemistry 29: 3813, 1990.
24. Hendey, B., Klee, C. B., and Maxfield, F. R. Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science 258: 296, 1992.
25. Jayaraman, T., Brillantes, A. M., Timerman, A. P., et al. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267: 9474, 1992.
26. Naito, M., Oh-hara, T., Yamazaki, A., et al. Reversal of multidrug resistance by an immunosuppressive agent FK-506. Cancer Chemother. Pharmacol. 29: 195, 1992.
27. Yusa, K., and Tsuruo, T. Reversal mechanism of multidrug resistance by verapamil: Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 49: 5002, 1989.
28. Tsuruo, T. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics. Cancer Treat. Rep. 67: 889, 1983.
29. Kawano, K., Kim, Y. I., Goto, S., et al. A protective effect of FK 506 in ischemically injured rat livers. Transplantation 52: 143, 1991.
30. Wakabayashi, H., Karasawa, Y., Maeba, T., et al. Effect of FK 506 and cyclosporine A on hepatic energy status in the rat after warm ischemia, as monitored by 31P nuclear magnetic resonance spectroscopy in vivo. Trans. Proc. 24: 1993, 1992.
31. Sakr, M. F., McClain, C. J., Gavaler, J. S., et al. FK 506 pretreatment is associated with reduced level of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. J. Hepatol. 17: 301, 1993.